Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, July 7, 2015, 32 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $11.64 to $2,178,000.00.

Highlighted Stocks Traded by Insiders:

Dycom Industries (DY) - FREE Research Report

Coe Charles B, who is Director at Dycom Industries, bought 2,500 shares at $64.14 on July 7, 2015. Following this transaction, the Director owned 61,504 shares meaning that the stake was boosted by 4.24% with the 2,500-share transaction.

The shares most recently traded at $65.41, up $1.27, or 1.94% since the insider transaction. Historical insider transactions for Dycom Industries go as follows:

  • 4-Week # shares bought: 15,000
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 1,000

The average volume for Dycom Industries has been 365,400 shares per day over the past 30 days. Dycom Industries has a market cap of $2.3 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 88.46% year-to-date as of the close of trading on Tuesday.

Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. The company has a P/E ratio of 34.6. Currently, there are 6 analysts who rate Dycom Industries a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DY - FREE

TheStreet Quant Ratings

rates Dycom Industries as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and good cash flow from operations. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Dycom Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ClubCorp Holdings (MYCC) - FREE Research Report

McClellan Curtis D, who is CFO & Treasurer at ClubCorp Holdings, sold 13,200 shares at $23.98 on July 7, 2015. Following this transaction, the CFO & Treasurer owned 111,625 shares meaning that the stake was reduced by 10.57% with the 13,200-share transaction.

The shares most recently traded at $24.18, up $0.20, or 0.84% since the insider transaction. Historical insider transactions for ClubCorp Holdings go as follows:

  • 4-Week # shares bought: 5,300
  • 4-Week # shares sold: 15,000
  • 12-Week # shares bought: 5,300
  • 12-Week # shares sold: 13.8 million
  • 24-Week # shares bought: 5,300
  • 24-Week # shares sold: 13.9 million

The average volume for ClubCorp Holdings has been 525,900 shares per day over the past 30 days. ClubCorp Holdings has a market cap of $1.6 billion and is part of the services sector and leisure industry. Shares are up 35.42% year-to-date as of the close of trading on Tuesday.

ClubCorp Holdings, Inc., a membership-based leisure company, owns and operates golf, country, business, sports, and alumni clubs in North America. It operates in two segments, Golf and Country Clubs; and Business, Sports, and Alumni Clubs. The stock currently has a dividend yield of 2.16%. The company has a P/E ratio of 120.5. Currently, there are 7 analysts who rate ClubCorp Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MYCC - FREE

TheStreet Quant Ratings

rates ClubCorp Holdings as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk and poor profit margins. Get the full

ClubCorp Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Haemonetics (HAE) - FREE Research Report

White Jonathan, who is Chief Science and Technology at Haemonetics, sold 2,385 shares at $41.14 on July 7, 2015. Following this transaction, the Chief Science and Technology owned 25,620 shares meaning that the stake was reduced by 8.52% with the 2,385-share transaction.

The shares most recently traded at $39.78, down $1.36, or 3.42% since the insider transaction. Historical insider transactions for Haemonetics go as follows:

  • 4-Week # shares sold: 406
  • 12-Week # shares sold: 406
  • 24-Week # shares sold: 406

The average volume for Haemonetics has been 316,700 shares per day over the past 30 days. Haemonetics has a market cap of $2.1 billion and is part of the health care sector and health services industry. Shares are up 6.97% year-to-date as of the close of trading on Tuesday.

Haemonetics Corporation designs, manufactures, and markets blood management solutions. The company operates through North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific, and Japan segments. The company has a P/E ratio of 126.0. Currently, there is 1 analyst who rates Haemonetics a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAE - FREE

TheStreet Quant Ratings

rates Haemonetics as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

Haemonetics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.